Wells Fargo’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Wells Fargo’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-66,920	Closed	-$4M	–	7273
2020 Q2	$4M	Buy	66,920 +27,299	+69%	+$1.69M	﹤0.01%	2686
2020 Q1	$2.35M	Sell	39,621 -5,580	-12%	-$325K	﹤0.01%	2857
2019 Q4	$2.48M	Buy	45,201 +17,195	+61%	+$642K	﹤0.01%	3181
2019 Q3	$790K	Buy	28,006 +2,755	+11%	+$101K	﹤0.01%	4026
2019 Q2	$838K	Buy	25,251 +14,248	+129%	+$445K	﹤0.01%	4003
2019 Q1	$375K	Buy	11,003 +533	+5%	+$17K	﹤0.01%	4503
2018 Q4	$287K	Buy	10,470 +10,370	+10,370%	+$267K	﹤0.01%	4701
2018 Q3	$3K	Buy	+100	New	+$2.82K	﹤0.01%	6206

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Wells Fargo's PRNB Position: Q3 2020 in Review

Wells Fargo sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 66,920 shares — an estimated $4M sold.

Wells Fargo first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $4M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Wells Fargo reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Wells Fargo sold 66,920 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $4M.
Wells Fargo first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Wells Fargo's Principia Biopharma Inc. Common Stock position peaked at $4M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Wells Fargo's 13F filing for Q3 2020, filed 5 Nov 2020.